Spero Therapeutics

Spero Therapeutics

  • Founded: 2013
  • Location: Cambridge, MA
  • Employee range: 50 - 200
  • Clinical stage: Clin3
  • Therapy area: UTI
  • Drug types: INF
  • Lead product: Tebipenem HBr
  • Product link: https://www.sperotherapeutics.com/pipeline/spero-pipeline
  • Funding: $5.9M grant Jul 2019; $77M IPO Nov 2017


sperotherapeutics.com

linkedin.com

job board


Short description:

Anti-infectives

Drug notes:

SPR720 Clin2 NTM infection; SPR206 Clin1 hospital bacterial infections

Long description:

Contact us to add description: recruit@workinbiotech.com

Jobs:


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com